CTOs on the Move

Audentes Therapeutics

www.audentestx.com

 
Audentes is a biotechnology company committed to the development and commercialization of innovative new medicines for people with serious, rare muscle diseases. We are a passionate, energetic team driven by the goals of improving the lives of patients and building a successful business. We take pride in strong, global relationships with the patient, research, and medical communities.
  • Number of Employees: 100-250
  • Annual Revenue: $500M-1 Billion
  • www.audentestx.com
  • 600 California Street 17th Floor
    San Francisco, CA USA 94108
  • Phone: 415.638.6556

Executives

Name Title Contact Details
John Gray
 Senior Vice President and Chief Technology Officer Profile

Funding

Audentes Therapeutics raised $137.5M on 10/13/2015

Similar Companies

B-Bridge International

B-Bridge International is a Cupertino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alberta Conservation Association

Alberta Conservation Association is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

64x Bio

64x Bio is transforming the future of cell and gene therapy manufacturing with high throughput discovery and design of enhanced cell lines for next-generation biomanufacturing and therapeutics.

Adjuvance Technologies

Helping protect life through fundamental breakthroughs in vaccine adjuvant design and manufacturing.

Diagnostic Solutions Laboratory

We are pleased to offer clinicians the first of many advances, the GI-MAP™. The GI-MAP™ (GI-Microbial Assay Plus) stool test utilizes cutting edge, FDA-approved technology to provide a true DNA/PCR based stool analysis which provides actionable informa...